Terms: = Sarcomas AND TOP2A, TOP2, TP2A AND Treatment
11 results:
1. Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome.
Trujillo-Paolillo A; Tesser-Gamba F; Seixas Alves MT; Filho RJG; Oliveira R; Petrilli AS; Toledo SRC
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982681
[TBL] [Abstract] [Full Text] [Related]
2. In vitro anti-synovial sarcoma effect of diallyl trisulfide and mRNA profiling.
Xia SL; Ma ZY; Wang B; Gao F; Yi CG; Zhou XX; Guo SY; Zhou L
Gene; 2022 Mar; 816():146172. PubMed ID: 34995734
[TBL] [Abstract] [Full Text] [Related]
3. Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma.
Godel M; Morena D; Ananthanarayanan P; Buondonno I; Ferrero G; Hattinger CM; Di Nicolantonio F; Serra M; Taulli R; Cordero F; Riganti C; Kopecka J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599901
[TBL] [Abstract] [Full Text] [Related]
4. Molecular variations in uterine carcinosarcomas identify therapeutic opportunities.
Crane E; Naumann W; Tait D; Higgins R; Herzog T; Brown J
Int J Gynecol Cancer; 2020 Apr; 30(4):480-484. PubMed ID: 32114514
[TBL] [Abstract] [Full Text] [Related]
5. Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma.
Adams CL; Dimitrova I; Post MD; Gibson L; Spillman MA; Behbakht K; Bradford AP
Exp Mol Pathol; 2019 Oct; 110():104284. PubMed ID: 31301306
[TBL] [Abstract] [Full Text] [Related]
6. Expression and inhibition of BRD4, EZH2 and top2a in neurofibromas and malignant peripheral nerve sheath tumors.
Amirnasr A; Verdijk RM; van Kuijk PF; Taal W; Sleijfer S; Wiemer EAC
PLoS One; 2017; 12(8):e0183155. PubMed ID: 28813519
[TBL] [Abstract] [Full Text] [Related]
7. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
[TBL] [Abstract] [Full Text] [Related]
8. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
Deng S; Yan T; Nikolova T; Fuhrmann D; Nemecek A; Gödtel-Armbrust U; Kaina B; Wojnowski L
Br J Pharmacol; 2015 May; 172(9):2246-57. PubMed ID: 25521189
[TBL] [Abstract] [Full Text] [Related]
9. Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.
Peacock JD; Cherba D; Kampfschulte K; Smith MK; Monks NR; Webb CP; Steensma M
J Transl Med; 2013 Sep; 11():213. PubMed ID: 24040940
[TBL] [Abstract] [Full Text] [Related]
10. Sensitivity to top2 targeting chemotherapeutics is regulated by Oct1 and FILIP1L.
Lu H; Hallstrom TC
PLoS One; 2012; 7(8):e42921. PubMed ID: 22900064
[TBL] [Abstract] [Full Text] [Related]
11. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma.
Crago AM; Singer S
Curr Opin Oncol; 2011 Jul; 23(4):373-8. PubMed ID: 21552124
[TBL] [Abstract] [Full Text] [Related]